CAS: 1600515-49-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Tilfrinib REF: IN-DA00ATFECAS: 1600515-49-8 | 98% | To inquire | Thu 23 Jan 25 |
 | Tilfrinib REF: TM-T17098CAS: 1600515-49-8 | 99.73% | 45.00 €~1,374.00 € | Thu 13 Mar 25 |
 | Tilfrinib REF: 3D-APC51549CAS: 1600515-49-8 | Min. 95% | - - - | Discontinued product |
Ref: IN-DA00ATFE
| 1mg | 167.00 € | ||
| 5mg | 597.00 € | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Thursday 23 Jan 2025
Tilfrinib
CAS:1600515-49-8
Tilfrinib is an effective and selective inhibitor of breast tumor kinase(Brk, IC50 = 3.15 nM) …
Formula:
C17H13N3O
Purity:
99.73%
Color and Shape:
Solid
Molecular weight:
275.3
Ref: TM-T17098
| 1mg | 45.00 € | ||
| 2mg | 59.00 € | ||
| 5mg | 96.00 € | ||
| 10mg | 134.00 € | ||
| 25mg | 250.00 € | ||
| 50mg | 455.00 € | ||
| 100mg | 665.00 € | ||
| 500mg | 1,374.00 € | ||
| 1mL*10mM (DMSO) | 87.00 € |
Estimated delivery in United States, on Thursday 13 Mar 2025
Tilfrinib
CAS:1600515-49-8
Tilfrinib is a drug that binds to the epidermal growth factor receptor (EGFR) and inhibits …
Formula:
C17H13N3O
Purity:
Min. 95%
Molecular weight:
275.3 g/mol
Ref: 3D-APC51549
| 1mg | Discontinued | Request information | |
| 5mg | Discontinued | Request information | |
| 10mg | Discontinued | Request information | |
| 25mg | Discontinued | Request information | |
| 50mg | Discontinued | Request information |
